tiprankstipranks
Sorrento Therapeutics (SRNE)
OTHER OTC:SRNE
US Market

Sorrento Therapeutics (SRNE) Cash flow

Compare
5,267 Followers

Sorrento Therapeutics Cash Flow

SRNE's free cash flow for Q2 2023 was $-55.80M. For the 2023 fiscal year, SRNE's free cash flow was decreased by $-16.82M and operating cash flow was $-55.66M. See a summary of the company’s cash flow.
Cash Flow
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -293.86M$ -281.82M$ -159.54M$ -173.00M$ -111.77M
Investing Cash Flow
$ -28.52M$ 79.85M$ -39.92M$ -38.17M$ -21.20M
Financing Cash Flow
$ 311.72M$ 181.33M$ 174.24M$ 78.89M$ 326.00M
End Cash Position
$ 23.63M$ 36.66M$ 56.46M$ 80.77M$ 168.33M
Free Cash Flow
$ -307.51M$ -290.69M$ -197.12M$ -184.44M$ -132.96M
Currency in USD

Sorrento Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis